Charles Schwab’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-688,406
Closed -$26.6M 3746
2023
Q1
$26.6M Buy
688,406
+8,685
+1% +$280K 0.01% 1258
2022
Q4
$14.6M Buy
679,721
+26,053
+4% +$545K ﹤0.01% 1644
2022
Q3
$16M Sell
653,668
-120,255
-16% -$3.18M 0.01% 1537
2022
Q2
$12.7M Buy
773,923
+11,331
+1% +$220K ﹤0.01% 1708
2022
Q1
$20.5M Buy
762,592
+17,369
+2% +$366K 0.01% 1527
2021
Q4
$24.7M Buy
745,223
+15,776
+2% +$597K 0.01% 1408
2021
Q3
$31M Buy
729,447
+708,032
+3,306% +$38M 0.01% 1195
2021
Q2
$1.25M Buy
21,415
+6,693
+45% +$398K ﹤0.01% 2853
2021
Q1
$799K Buy
14,722
+2,529
+21% +$141K ﹤0.01% 2926
2020
Q4
$746K Sell
12,193
-634
-5% -$33.3K ﹤0.01% 2866
2020
Q3
$686K Buy
+12,827
New +$574K ﹤0.01% 2789

Other funds holding OSH

Charles Schwab's OSH Position: Q2 2023 in Review

Charles Schwab sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 688,406 shares — an estimated $26.6M sold.

Charles Schwab first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $31M in Q3 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Charles Schwab reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Charles Schwab sold 688,406 Oak Street Health, Inc. shares in Q2 2023, an estimated $26.6M.
  • Charles Schwab first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
  • Charles Schwab's Oak Street Health, Inc. position peaked at $31M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.